Physician profile
Eric Steven Goldschmidt
NPI 1760914626
$9,066.80
in general payments reported to CMS, 2019-2025
11 companies · $5,872 in 2025
The $5,872 reported for 2025 was more than what 86% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.45 · 2022: $50.65 · 2023: $949 · 2024: $2,179 · 2025: $5,872.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,735 · Travel and Lodging: $2,462 · Education: $803.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,734.97 |
| Travel and Lodging | $2,461.91 |
| Education | $802.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,554.97 | 2023-2025 | Endurant Iis, Turbohawk, Valiant Captivia |
| Penumbra, INC. | $1,615.56 | 2025 | Indigo System |
| W. L. Gore & Associates, INC. | $1,146.92 | 2025 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Acuseal Vascular Graft, Gore Viabahn Endoprosthesis |
| Boston Scientific Corporation | $573.96 | 2023-2025 | Eluvia, General - Thrombectomy, General - Vascular Intervention |
| Shockwave Medical, INC | $565.45 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $193.21 | 2024-2025 | Diamondback Peripheral, Esprit |
| Silk Road Medical, INC. | $177.37 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Davol INC. | $147.13 | 2024 | Arista Ah Flexitip |
| Integra Lifesciences Corporation | $50.65 | 2022 | |
| Smith+Nephew, INC. | $25.13 | 2025 | Grafix Pl |
| Allergan, INC. | $16.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Goldschmidt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.